The expression levels of EMB, LDHA, SLC16A1, SLC16A3, SLC16A8, PARK7, and PFKFB2 were lower in 1p/19q Codel glioma than those in non-Codel glioma (Figure 1A). Here, SLC16A3 is linked to central nervous system cancer.